Rosanna Coppo
#167,640
Most Influential Person Now
Researcher
Rosanna Coppo's AcademicInfluence.com Rankings
Rosanna Coppocomputer-science Degrees
Computer Science
#10201
World Rank
#10697
Historical Rank
Computational Linguistics
#2573
World Rank
#2598
Historical Rank
Machine Learning
#4668
World Rank
#4720
Historical Rank
Artificial Intelligence
#5030
World Rank
#5095
Historical Rank
Download Badge
Computer Science
Rosanna Coppo's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Rosanna Coppo Influential?
(Suggest an Edit or Addition)Rosanna Coppo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. (2009) (1022)
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. (2009) (848)
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. (2017) (609)
- Genome-wide association study identifies susceptibility loci for IgA nephropathy (2011) (524)
- An international consensus approach to the management of atypical hemolytic uremic syndrome in children (2015) (438)
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens (2014) (430)
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments (2014) (346)
- Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. (2014) (263)
- IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. (2007) (215)
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial (2017) (213)
- Predictors of outcome in Henoch-Schönlein nephritis in children and adults. (2006) (204)
- A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. (2017) (199)
- Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. (1997) (194)
- Factors predicting progression of IgA nephropathies. (2005) (194)
- Henoch–Schönlein purpura nephritis in children (2014) (184)
- Aberrant glycosylation in IgA nephropathy (IgAN). (2004) (182)
- Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (179)
- Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. (2019) (174)
- The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. (2010) (171)
- Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study. (2015) (170)
- Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. (1982) (138)
- Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. (2001) (118)
- Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (113)
- The MEST score provides earlier risk prediction in lgA nephropathy. (2016) (113)
- Immunological basis of inflammation in dialysis. (2002) (111)
- Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic (1999) (108)
- The MEST score provides earlier risk prediction in IgA nephropathy. (2015) (104)
- Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers (2012) (102)
- Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. (2011) (101)
- Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey (2018) (100)
- Toll‐like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy (2010) (99)
- Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. (2012) (96)
- Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors. (1993) (90)
- Effects of a gluten-free diet in primary IgA nephropathy. (1990) (85)
- Innate immunity and IgA nephropathy. (2010) (83)
- Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. (1997) (81)
- Gluten-induced experimental IgA glomerulopathy. (1989) (81)
- Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. (1997) (79)
- IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. (1984) (76)
- Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. (2000) (75)
- In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura (2006) (71)
- Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. (2009) (70)
- Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy (2014) (67)
- Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
- The intestine-renal connection in IgA nephropathy. (2015) (64)
- Mediterranean diet and primary IgA nephropathy. (1986) (64)
- Enhanced production of nitric oxide by blood-dialysis membrane interaction. (1995) (62)
- Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. (2010) (62)
- Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort (2016) (62)
- Angiotensin II local hyperreactivity in the progression of IgA nephropathy. (1993) (60)
- Dietary antigens and primary immunoglobulin A nephropathy. (1992) (59)
- The Gut-Renal Connection in IgA Nephropathy. (2018) (58)
- The gut–kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition (2017) (58)
- Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy (2015) (57)
- IgA nephropathy and infections (2016) (54)
- Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients (2017) (53)
- Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. (2000) (51)
- Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. (1994) (51)
- Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–Schönlein purpura nephritis (2013) (50)
- Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
- Corticosteroids in IgA Nephropathy: Lessons from Recent Studies. (2017) (49)
- Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers. (2020) (48)
- Serum IgA and macromolecular IgA reacting with mesangial matrix components. (1993) (48)
- Biomarkers and targeted new therapies for IgA nephropathy (2017) (48)
- Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch–Schönlein purpura and primary IgA nephropathy (2014) (48)
- Reference values of the bioelectrical impedance vector in neonates in the first week after birth. (2002) (46)
- Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. (2004) (46)
- Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. (1995) (46)
- Pediatric IgA nephropathy: clinical and therapeutic perspectives. (2008) (45)
- Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. (2013) (45)
- Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. (2009) (45)
- Dietary gluten and primary IgA nephropathy. (1986) (45)
- Risk factors for poor renal prognosis in children with hemolytic uremic syndrome (2003) (44)
- Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology. (1998) (43)
- IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian, and Japanese IgA nephropathy patients. (1991) (42)
- Role of monocytes in cryoglobulinemia-associated nephritis. (1993) (42)
- Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: removal of IgA-containing circulating immune complexes and clinical recovery. (1985) (41)
- The pathogenetic potential of environmental antigens in IgA nephropathy. (1988) (40)
- Immunogenetics of Henoch-Schoenlein disease. (1997) (40)
- Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. (2000) (39)
- The polymorphonuclear neutrophil (PMN) immunohistological technique: detection of immune complexes bound to the PMN membrane in acute poststreptococcal and lupus nephritis. (1980) (38)
- Glucose degradation products increase apoptosis of human mesothelial cells. (2003) (38)
- Glomerular findings in mixed IgG-IgM cryoglobulinemia (1976) (38)
- Properties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura in adults and in children. (1997) (35)
- Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? (1992) (35)
- Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression. (2019) (34)
- The emergency management of severe hypertension (2000) (33)
- Tubulointerstitial responses in the progression of glomerular diseases: Albuminuria modulates αvβ5 integrin (1996) (32)
- Clinical features of Henoch-Schönlein purpura. Italian Group of Renal Immunopathology. (1999) (32)
- In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. (2002) (31)
- Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker. (2017) (31)
- Functional changes of monocytes due to dialysis membranes. (1989) (30)
- IgA nephropathy at two score and one. (2010) (30)
- Role of Apoptosis in Pathogenesis and Progression of Renal Diseases (2000) (30)
- Bradykinin and nitric oxide generation by dialysis membranes can be blunted by alkaline rinsing solutions. (2000) (30)
- The fate of aggregated immunoglobulin A injected in IgA nephropathy patients and healthy controls. (1991) (30)
- Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritis. (1985) (29)
- The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus. (2004) (29)
- Development and testing of an artificial intelligence tool for predicting end stage kidney disease in patients with immunoglobulin A nephropathy. (2020) (29)
- Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. (1986) (28)
- Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation (2007) (28)
- Treatment of IgA nephropathy: Recent advances and prospects. (2018) (28)
- Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. (1994) (28)
- Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. (2005) (28)
- Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study. (1995) (27)
- Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. (1992) (27)
- Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? (2015) (27)
- [Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study]. (2011) (26)
- Oxidative Stress in IgA Nephropathy (2010) (26)
- Clearance of polymeric IgA aggregates in humans. (1989) (26)
- Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. (2020) (25)
- The Influence of Peritoneal Dialysis on Cellular Immunity (1981) (25)
- Idiopathic nephropathy with IgA deposits (2000) (25)
- One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. (2005) (24)
- Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. (2018) (24)
- Macromolecular properties that promote mesangial binding and mesangiopathic nephritis. (1992) (24)
- New perspectives in treatment of glomerulonephritis (2004) (24)
- IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. (1995) (24)
- IgA nephropathy in children and in adults: two separate entities or the same disease? (2020) (23)
- Proteasome inhibitors in progressive renal diseases. (2014) (23)
- Outcome of childhood-onset full-house nephropathy (2016) (23)
- Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study. (2012) (22)
- Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. (1995) (21)
- Classi fi cation of IgA nephropathy 2016 — the role of crescentic lesions : an update from the IgA Nephropathy Classi fi cation Working Group (2017) (21)
- Liver transplantation for aHUS: still needed in the eculizumab era? (2016) (21)
- Circulating Fc-receptor blocking factors in IgA nephropathies. (1985) (20)
- Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3. (2012) (20)
- Pediatric IgA Nephropathy in Europe (2019) (20)
- Bone alterations in children and young adults with renal transplant assessed by phalangeal quantitative ultrasound. (2007) (20)
- Monoclonal gammopathy and glomerulonephritis with organized microtubular deposits. (1990) (20)
- Cytokine mRNA expression by cultured rat mesangial cells after contact with environmental lectins. (1993) (20)
- The new Oxford Clinico-Pathological Classification of IgA nephropathy. (2010) (20)
- The mucosal immune system and IgA nephropathy (2021) (19)
- Is a legacy effect possible in IgA nephropathy? (2013) (19)
- Procalcitonin as a marker of micro-inflammation in hemodialysis. (2005) (19)
- Different targets for treating focal segmental glomerular sclerosis. (2013) (18)
- Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy. (2020) (18)
- Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. (2020) (18)
- Treatment of IgA nephropathy in children: a land without KDIGO guidance (2020) (17)
- Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation. (1993) (17)
- ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study. (2006) (17)
- The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy (2015) (17)
- International IgA nephropathy network clinico-pathological classification of IgA nephropathy. (2007) (17)
- Complications Linked to Chronic Peritoneal Dialysis in Children after Kidney Transplantation: Experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis (1996) (17)
- Immunological monitoring of plasma exchange in primary IgA nephropathy. (1985) (16)
- Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis. (2018) (16)
- Challenges in pediatric renal transplantation. (2014) (15)
- C4d deposits in IgA nephropathy: where does complement activation come from? (2017) (15)
- Treatment of rapidly progressive IgA nephropathy. (1995) (15)
- N-Acetylcysteine in hemodialysis diabetic patients resets the activation of NF-kB in lymphomonocytes to normal values. (2013) (15)
- Non-steroidal and non-cytotoxic therapies for nephrotic syndrome. (2008) (14)
- Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. (1996) (14)
- Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy. (2019) (14)
- Efficacy and safety of valsartan in hypertensive children 6 months to 5 years of age (2013) (14)
- Updating the International IgA Nephropathy Prediction Tool for use in children. (2020) (13)
- Glomerular diseases and transplantation: similarities in pathogenetic mechanisms and treatment options. (2011) (13)
- Low renin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves. (2005) (13)
- Plasma exchange in progressive primary IgA nephropathy. (1985) (13)
- Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging (2019) (13)
- Neonatal Sepsis with Multi-Organ Failure and Treated with a New Dialysis Device Specifically Designed for Newborns (2014) (13)
- Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease. (2019) (13)
- IgA vasculitis nephritis in children and adults: one or different entities? (2020) (13)
- Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy. (2018) (13)
- Angiotensin antagonists and fish oil for treating IgA nephropathy. (2007) (12)
- Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy? (2019) (12)
- IgA1 and IgA2 in circulating immune complexes and in renal deposits of Berger's and Schönlein-Henoch glomerulonephritis. (1983) (12)
- Failure to relate mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy. (1987) (12)
- Complications Linked to Chronic Peritoneal Dialysis in Children after Kidney Transplantation: Experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis (1996) (11)
- Can a dysregulated mucosal immune system in IgA nephropathy be controlled by tonsillectomy? (2010) (11)
- Microalbuminuria in single kidney patients: relationship with protein intake. (1988) (11)
- Modulation of Mesangial Cell Reactivity by Aberrantly Glycosylated IgA (2000) (11)
- Glomerular permeselectivity to macromolecules in reflux nephropathy: microalbuminuria during acute hyperfiltration due to aminoacid infusion (1994) (11)
- Monocyte-macrophage system function in primary IgA nephropathy. (1984) (11)
- Use of alkaline rinsing solution to prevent hypersensitivity reactions during hemodialysis: data from a multicentre retrospective analysis. (1999) (11)
- Importance of the bradykinin-nitric oxide synthase system in the hypersensitivity reactions of chronic haemodialysis patients. (2000) (11)
- Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome. (2006) (11)
- Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial. (2001) (11)
- Single kidney function: effect of acute protein and water loading on microalbuminuria. (1988) (10)
- [Neonatal chronic kidney failure associated with cyclo-oxygenase-2 inhibitors administered during pregnancy]. (2001) (9)
- Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications. (2011) (9)
- Quantitative and functional analysis of IgG Fc receptor molecules in polymorphonuclear leukocytes and monocyte macrophages in patients with essential mixed cryoglobulinaemia. (1987) (8)
- Glomerular findings in mixed IgG-IgM cryoglobulinemia. Light, electron microscopic, immunofluorescence and histochemical correlations. (1976) (8)
- Immune material processing by phagocyte cell system in cryoglobulinemia. (1991) (8)
- Ineffectiveness of phenytoin treatment on IgA-containing circulating immune complexes in IgA nephropathy. (1984) (8)
- IgA Nephropathy: A European Perspective in the Corticosteroid Treatment (2018) (8)
- Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis. (1991) (8)
- Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC). (1984) (8)
- Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. (1989) (8)
- Minimal change nephropathy (2009) (8)
- Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin. (1996) (8)
- Interaction between the macrophage system and IgA immune complexes in IgA nephropathy. (1983) (7)
- Lack of cardiac anomalies in children with NPHS2 mutations. (2007) (7)
- Glycated adducts induce mesothelial cell transdifferentiation: role of glucose and icodextrin dialysis solutions. (2008) (7)
- Heparin is unable to prevent contact activation by three different membranes. (1981) (7)
- Children with chronic organ failure possibly ending in organ transplantation: a survey in an Italian region of 5 000 000 inhabitants (2008) (7)
- Fc-receptor function of the mononuclear phagocyte system in glomerulonephritis secondary to some multisystem diseases. (1987) (7)
- Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells. (2009) (7)
- International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. (2021) (7)
- Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy. (2022) (7)
- How early renal biopsy has to be performed in children with isolated asymptomatic proteinuria? (2012) (7)
- Is hepatitis C virus RNA detectable in dialysis ultrafiltrate? (1996) (7)
- Effects of blood transfusion on cellular immunity. (1981) (7)
- In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS 13 in thrombotic thrombocytopenic purpura (2018) (6)
- Nitric oxide production with PMMA membrane. (1999) (6)
- Clinical significance of the detection of circulating immune complexes in lupus nephritis. (1982) (6)
- Influence of gluten-derived fractions on chemiluminescence production by human neutrophils. (1990) (6)
- An Enzyme Immunoassay to Detect Microalbuminuria in Diabetic Patients (1985) (6)
- Systemic corticosteroids and mucosal-associated lymphoid tissue-targeted therapy in IgA nephropathy: insight from the NEFIGAN study. (2019) (6)
- Toll-like receptors are essential for the control of endogenous retrovirus expression in Idiopathic Nephrotic Syndrome. (2016) (6)
- COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment? (2020) (6)
- Cyclosporin induces apoptosis of renal cells by enhancing nitric oxide synthesis: modulating effect of angiotensin II inhibitors. (2001) (6)
- Is HCV-RNA detectable in dialysis ultrafiltrate? (1993) (6)
- The inhibitory influence of dialysis treatment on E-rosette formation. (1982) (5)
- The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression. (2020) (5)
- Angiotensin-converting enzyme inhibitors in young patients with IgA nephropathy: effects against deterioration of renal function. A Biomedicine and Health Research Concerted Action. (1999) (5)
- The Phenotypic Difference of IgA Nephropathy and its Race/Gender-dependent Molecular Mechanisms. (2021) (4)
- Circulating immune complexes in nephritis (1977) (4)
- [Pathogenesis of systemic lupus erythematosus (LES)]. (2012) (4)
- Crescents and IgA Nephropathy: A Delicate Marriage (2022) (4)
- HERV-K and W expression in peripheral mononuclear cells of children with Henoch-Schönlein purpura and relation with TLRs activation. (2017) (4)
- Moderately proteinuric IgA nephropathy in the young (2000) (4)
- Experience in the computer handling of clinical data for dialysis and transplantation units: an Italian regional (Piedmont) registry. (1985) (4)
- A new test for IgA containing immune complexes or aggregated IgA: its application to Berger and Schönlein-Henoch nephritis. (1980) (4)
- Processing of IgA aggregates in a rat model of chronic liver disease. (1997) (4)
- In vitro study of Fc-receptor function in autoimmune diseases. (1985) (4)
- Providing the right stuff: feeding children with chronic renal failure. (1998) (4)
- The Kidney, a Victim and Culprit of Autoimmune and Alloimmune Responses (2011) (4)
- Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort (2016) (4)
- ORAL SESSION (2011) (3)
- Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: An interim long-term analysis (1991) (3)
- CHAPTER 18 – IgA Nephropathy (2008) (3)
- The role of integrins in IgA nephropathy (1997) (3)
- [Quantitative and qualitative determinations and clinical and histological correlations of cryoglobulins in glomerulonephritis]. (1982) (3)
- Wheat protein antigens and effector cells of aspecific immunity. (1990) (3)
- [Biocompatibility of the acetate in the dialysis fluid]. (2004) (3)
- Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure (2014) (3)
- Is progression of IgA nephropathy conditioned by genes regulating atherosclerotic damage? (2009) (3)
- Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease. (2021) (3)
- IN TRANSPLANTED PATIENTS (2002) (3)
- Differential diagnosis of thrombotic microangiopathy in nephrology (2017) (3)
- [Glomerulonephritis and renal sclerosis: new therapeutic proposals (review)]. (2004) (3)
- Circulating immune complexes in immunologically mediated glomerular diseases. (1985) (3)
- [Circulating immune complexes in glomerulonephritis]. (1982) (3)
- Plasma exchange in immune complex glomerulonephritis: clinical and immunological correlations. (1983) (3)
- Erythrocyte Na,Li Countertransport and Arterial Pressure in Diabetic Adolescents (1990) (3)
- FP112THE PROTEASOME TO IMMUNOPROTEASOME SWITCH IN IGA NEPHROPATHY AND ITS GENETIC CONTROL: A POST-VALIGA EUROPEAN RESEARCH STUDY (2015) (2)
- GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy (2021) (2)
- [Audit on quality of life of patients with chronic kidney disease on dialysis and after transplant]. (2008) (2)
- TO044A EUROPEAN REGISTRY OF HENOCH SCHOENLEINPURPURA NEPHRITIS IN CHILDREN TO DETECT RISK FACTORS FOR PROGRESSION (2016) (2)
- The influence of blood transfusion on cellular immunity. (1982) (2)
- TO013PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED‑RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL (2017) (2)
- Plasmapheresis influences the immune response affecting T cell subsets. (1983) (2)
- A new monoclonal antibody for detecting degalactosylated IgA1 as serum biomarker of IgA nephropathy. (2015) (2)
- Phenotypic and functional analysis of circulating phagocytic cells in IgA nephropathy patients. (1989) (2)
- A Focus Group Study of Self-Management in Patients With Glomerular Disease (2021) (2)
- A Core Outcome Set for Trials in Glomerular Disease (2021) (2)
- Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis (2013) (2)
- The implications of focal segmental glomerulosclerosis in children with IgA nephropathy (2019) (2)
- [Role of food antigens and alcohol in idiopathic nephritis with IgA deposits]. (1991) (2)
- [The role of steroids in the treatment of IgA nephropathy]. (2009) (2)
- Monocyte and macrophage Fc-receptor function in systemic vasculitis with renal involvement. (1984) (2)
- Paediatric renal transplantation (2018) (2)
- [Results of a generalized program of self-dialysis in the treatment of chronic uremina]. (1978) (2)
- A solid phase enzyme immunoassay for the measurement of urinary albumin and the detection of microalbuminuria. (1987) (2)
- IgA nephropathy in systemic diseases. (1989) (2)
- Acute kidney injury due to deferoxamine in a renal transplant patient. (2008) (2)
- Inhibition of experimental IgA nephropathy by colchicine. (1995) (2)
- Subject Index, Vol. 32, 1982 (1982) (1)
- MO041IMMUNOPROTEASOME PSMB8 MRNA EXPRESSION IS CORRELATED WITH ANNUAL LOSS OF GLOMERULAR FILTRATION RATE (EGFR SLOPE) IN IGAN PATIENTS ENROLLED IN VALIGA STUDY (2016) (1)
- Are circulating immune complexes and complement breakdown products useful for the detection of disease activity in nephrology? (1979) (1)
- Indication for corticosteroids in IgA nephropathy: validation in the European VALIGA cohort of a treatment score based on the Oxford classification. (2022) (1)
- The role of the ERA-EDTA in organizing continuing medical education in Europe for nephrology, dialysis and renal transplantation. (2006) (1)
- MO260PERFORMANCE ANALYSIS OF AN ARTIFICIAL NEURAL NETWORK TOOL TO PREDICT ESKD IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN) (2021) (1)
- A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. (2001) (1)
- IgA-fibronectin aggregates in IgA nephropathy. (1994) (1)
- ERA-EDTA Immunonephrology working group. (2010) (1)
- Antibiotics and Antiviral Drugs in the Intensive Care Unit (2009) (1)
- Reactivity of mesangial cells with aberrantly glycosylated IgA: modulation by angiotensin converting enzyme inhibitors (2002) (1)
- [Is HCV RNA detectable in the ultrafiltrate?]. (1996) (1)
- [Kidney transplantation in children]. (2005) (1)
- [Application of guidelines in clinical practice: a multicenter analysis of the treatment of membranous glomerulonephritis in Piedmont, Italy]. (2010) (1)
- Haemodynamic modulations in IgA nephropathy (1997) (1)
- 927 Sparsentan for treatment of pediatric patients with selected proteinuric glomerular diseases: design of the phase 2 EPPIK study (2022) (1)
- PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 1 (2014) (1)
- IgA containing material in monocytes from patients with IgA nephropathy. (1984) (1)
- [Dialysis in the old patient]. (1976) (1)
- [News on the etiopathogenesis and the treatment of Schoenlein-Henoch nephritis]. (2009) (1)
- Pediatric Renal Transplantation (1)
- Corticosteroid Therapy in Idiopathic Glomerulonephritis (1981) (1)
- ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap (2016) (1)
- Primary and secondary glomerulonephritis I (2012) (1)
- Response to ‘Nomenclature of the Oxford classification of IgA nephropathy: do we need to be careful?’ (2010) (1)
- [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis]. (2006) (1)
- A52 URINARY NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN) EXCRETION AT BIRTH IS PREDICTIVE OF SUSCEPTIBILITY TO ACUTE KIDNEY INJURY (AKI) IN VERY LOW BIRTH WEIGHT INFANTS (2013) (1)
- Glomerulonephritis with dense deposits: A variant of membranoproliferative glomerulonephritis or a separate morphological entity? (1980) (1)
- Henoch-Schoenlein purpura: The most common vasculitis in children with severe renal involvement (2004) (1)
- Phosphate-induced PTH stimulation and calcitriol treatment in children with early chronic renal insufficiency (1994) (1)
- Detection of PatIent-Level distances from single cell genomics and pathomics data with Optimal Transport (PILOT) (2022) (1)
- [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)]. (1982) (1)
- [Restrospective analysis of the renal biopsy activity in Piedmont]. (2012) (1)
- Minimal-change nephropathy and chronic hepatitis C infection : coincidental or associated ? (2007) (1)
- Protein-energy wasting (2013) (1)
- [Criteria of the biocompatibility of the membranes used in dialysis]. (1981) (1)
- Clinical Nephrology - Lab methods and other markers (2012) (1)
- [Bioincompatibility of acetate even at low concentrations]. (2011) (1)
- Treatment for IgA Nephropathy: Renin-Angiotensin Blockade (2009) (0)
- TUBULOINTERSTITIAL MESSAGES IN THE PROGRESSION OF GLOMERULAR-DISEASES - ALBUMINURIA MODULATES INTEGRIN EXPRESSION ON CULTURED TUBULAR CELLS (1995) (0)
- Macrophage function in primary and secondary glomerulonephritis. (1985) (0)
- [Cellular and humoral immunity in glomerulonephritis with minimal lesions]. (1980) (0)
- [IgA serology in idiopathic IgA deposit nephropathy in children]. (1994) (0)
- [Test of immune complex-polymorphonuclear leukocyte interaction in vivo. Comparison with the SP-Clq method of detection of immune complexes in the blood]. (1979) (0)
- The Significance of the Detection of Circulating Immune Complexes in Human Glomerulonephritis (1981) (0)
- Identification of pi3k as urine marker of IgA nephropathy using seldi-TOF mass spectrometry (2007) (0)
- Pregnancy and Oxidative Stress (2013) (0)
- CKD 5D epidemiology and outcomes (2012) (0)
- A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond. (2023) (0)
- [The need to expand research in renal disease among peripheral centers of nephrology - President's letter]. (2011) (0)
- Acknowledgement to the Reviewers (2011) (0)
- Association between genes conditioning low renal-angiotensin system activity and PUV with severe renal dysplasia. (2004) (0)
- Vasculitis (ANCA negative) (2012) (0)
- [Renal biopsy in the anatomo-clinical evaluation of lupus nephropathy]. (1978) (0)
- [Home dialysis. Treatment of choice?]. (1979) (0)
- PROTEASOMES ARE THE TARGET OF ANGIOTENSIN II INHIBITION THERAPY (2002) (0)
- [Dialysis as a system integrated into nephrology care (project no. 3 of the Italian Society of Nephrology) - president's letter]. (2011) (0)
- [Lessons learned from the research project ''Institutional formats and organizational models for the range of services in nephrology'']. (2012) (0)
- MO028PROGRESSIVE IGA NEPHPHROPATHY AND DEFECTIVE COMPLEMENT INHIBITOR CD46 MRNA EXPRESSION (2016) (0)
- Tubular cells trans-differentiation induced by allogenic response can be modulated by cyclo-oxygenase-2 inhibitors. (2001) (0)
- Immunoglobulin a 1 and immunoglobulin a 2 subclass immunocomplexes in patients with chronic alcoholic liver diseases with and without immunoglobulin a glomerulonephritis (1984) (0)
- [Microhematuria and hypercalciuria in children]. (1994) (0)
- [Solid-phase conglutinin tests for circulating IgA immunocomplexes]. (1982) (0)
- Role of genetic polymorphisms in the pathogenesis of IgAN (2009) (0)
- EFFICACY AND SAFETY OF VALSARTAN IN HYPERTENSIVE CHILDREN 6 MONTHS TO 5 YEARS OF AGE: A RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE STUDY: PP.27.86 (2010) (0)
- Non immunological therapy in nephropathies leading to chronic kidney disease and post transplant (2009) (0)
- Long-term prognosis of Henoch–Scho¨nlein nephritis in adults and children* (1997) (0)
- Abstracts for the IPNA Congress, 30 August – 3 September 2013, Shanghai, China (2013) (0)
- [SIN census 2008: the nephrologist's workload]. (2011) (0)
- Intermittent Complement activation during dialysis session as an important cause of chronic hypocomplementemia in patients on regular dialysis therapy (1981) (0)
- Referees 2007 (2007) (0)
- The influence of HLA-A and -B matched blood transfusions on immune response. (1983) (0)
- Beyond the Differences in Tonsillectomy in IgA Nephropathy: From Rationale To Indications in Patients (2016) (0)
- Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis. (1991) (0)
- [Influence of the dialysis bath in the control of arterial hypertension in patients receiving regular hemodialytic treatment]. (1974) (0)
- Paediatric nephrology - A (2013) (0)
- Cardiovascular complications in CKD 5D (2) (2011) (0)
- CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
- [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction]. (1980) (0)
- [Relationship between the Italian Society of Nephrology and ERA-EDTA: a new way of introducing young nephrologists to Europe (letter from President)]. (2012) (0)
- Defective function with normal expression of cell-surface Fc Receptors in mixed cryoglobulinemia (1985) (0)
- Altered glycosilation of serum IgA in patients with IgA nephropathy (1994) (0)
- Baseline Report on ”Biomonitoring of Children” in the framework of the European Environment and Health Strategy: Executive Summary (2003) (0)
- [A new test (conglutinin solid phase with anti IgA) for the detection of serum immune complexes in IgA antibody components]. (1980) (0)
- Glomerulopatia immunotactoide: presentazione di 8 casi clinici. (1988) (0)
- Immunoglobulin A Nephropathy in Children (2021) (0)
- Note from the ERA-EDTA (2007) (0)
- Incidence of new diabetic patients on dialysis in Piedmont, Italy: Major changes recorded over a 10-year period (1992) (0)
- [Regulation of ultrafiltration in plate and coil dialysis apparatus]. (1974) (0)
- [Optimization of the treatment of idiopathic nephrotic syndrome in children]. (1994) (0)
- [Use of operations research methods in decision making pertaining to the size of a hemodialysis center]. (1974) (0)
- International Physicians Delphi Survey: Managing Patients With IgA Nephropathy (2022) (0)
- Reviews submitted from August 1st, 2006 to August 31st, 2007 (2007) (0)
- [Lupus nephropathy. Hematic, tissue and urinary signs of coagulation involvement]. (1981) (0)
- [Initial results in the treatment with short-term dialysis]. (1976) (0)
- [The kidney transplant recipient]. (2011) (0)
- Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort (2019) (0)
- [Current trends and criteria in choice of frequency of dialytic treatments]. (1974) (0)
- Contents, Vol. 36, 1984 (1984) (0)
- Subject Index, Vol. 62, 1992 (2004) (0)
- [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis]. (1979) (0)
- [Cell-mediated immunity and dialysis: therapeutic possibilities with bovine thymic factor]. (1980) (0)
- FP153TREE BASED MODELS FOR THE PREDICTION OF IGAN PROGRESSION IN YOUNG PATIENTS (2015) (0)
- Baseline Report on ”Biomonitoring of Children” in the framework of the European Environment and Health Strategy: Revised baseline report (2003) (0)
- MO040 RISK FACTORS FOR PROGRESSION IN CHILDREN WITH IgA NEPHROPATHY: DATA FROM A EUROPEAN COHORT (2013) (0)
- [Italian Society of Nephrology 2011-2012: work in progress, accomplished, and planned - letter from president]. (2012) (0)
- Commentary on the article by G. Filler et al. (2001) (0)
- Clinical Nephrology: primary and secondary glomerulonephritis (2011) (0)
- IgAlandIgA2immunecomplexes inprimary IgAnephropathy andHenoch-Schonlein nephritis (1984) (0)
- The authors reply:. (2015) (0)
- FP839INDOLEAMINE 2,3-DIOXYGENASE (IDO) UPREGULATION IS AN INDEPENDENT PREDICTOR OF SUSCEPTIBILITY TO INFECTIONS IN KIDNEY TRANSPLANT PATIENTS (2015) (0)
- Metabolic and other complications of ESRD - 2 (2009) (0)
- IgA Nephropathy from the VALIGA European Study: Differences in Treatment Approaches Within Europe (2016) (0)
- Oxidative Stress in IgA Nephropathy. Commentary (2010) (0)
- Acetate free buffer mitigates the inflammatory reactions due to dialysis fluid bioincompatibility (2001) (0)
- Subject Index, Vol. 36, 1984 (1984) (0)
- Reactivity of mesangial cells with aberrantly glycosylated IgA: modulation by angiotensin‐converting enzyme inhibitors (2002) (0)
- P0350THE DURATION OF PROTEINURIA REMISSION AND CLINICAL OUTCOMES IN IGA NEPHROPATHY (2020) (0)
- Minimal change disease (2019) (0)
- Renal transplantation in patients with primary IgA nephropathy: risk of recurrence and renal allograft loss (2008) (0)
- [Immunopathological bases of the treatment of glomerulonephritis]. (1978) (0)
- [Dialysis in high risk patients. Problems and results]. (1976) (0)
- Graft endothelium and chronic allograft nephropathy: insight from in vitro trans-differentiation of smooth muscle cells induced by mismatched lymphocytes. (2001) (0)
- [Non-immunological therapy in nephropathies leading to chronic renal failure and in post-transplant chronic renal dysfunction]. (2008) (0)
- IPNA–ESPN Junior Master Class—a decade of successful continuing education and training in pediatric nephrology (2023) (0)
- Renal transplantation and immunosuppressive therapy do not contraindicate stem-cell donation for bone-marrow transplantation. (2003) (0)
- Contents, Vol. 32, 1982 (1982) (0)
- Dendrin in IgA nephropathy: protective or marker of early disease? (2022) (0)
- [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment]. (1974) (0)
- Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease. (1980) (0)
- Full Reviews The intestine – renal connection in IgA nephropathy (2015) (0)
- [Use of coil negative pressure in the kidney]. (1975) (0)
- Announcements – Book Review (2000) (0)
- Blood transfusion and cellular immunity. (1982) (0)
- Renal transplantation in insulin dependent diabetics. (1982) (0)
- Transplantation: basic science (2013) (0)
- [SIN census 2008: the management model]. (2012) (0)
- SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE (2017) (0)
- [Semeiotic significance of the clinical use of methods of determining serum immunocomplexes in human glomerulonephritis]. (1981) (0)
- PAEDIATRIC NEPHROLOGY MP707 CHARACTERISTICS AND OUTCOMES OF CHILDRENWITH AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE COHORT FROM THE ESPN/ERA-EDTA REGISTRY (2014) (0)
- Synergistic Antifungal Effect of Caspofungin and Human Polymorphonuclear Leukocytes (PMNs) from Chronic Haemodialysed Patients and Renal Transplant Recipients against Candida albicans (2010) (0)
- Interaction among medical specialists. (2012) (0)
- AKI - human studies (2013) (0)
- [Symptomatology and clinical aspects of inadequate dialysis]. (1975) (0)
- Renal transplantation - clinical studies - 2 (2009) (0)
- Maximizing the value of the open label extension phase of randomized clinical trials (2023) (0)
- On behalf of the Working Group of the International IgA Nephropathy Network & Renal Pathology Society (2010) (0)
- [Morphological criteria for the diagnostic definition of "dense deposit disease" (DDD)]. (1979) (0)
- [A severe case of nephrotic syndrome]. (2004) (0)
- [Management of a national society of nephrology: looking back on two years' experience as its president]. (2012) (0)
- [Renal biopsy practice in Piedmont and Valle d'Aosta]. (2012) (0)
- Applicationof the guidelines into clinical practice: A multicenter analysis of the treatmentof membranous glomerulonephritis in Piedmont (2010) (0)
- [Nephrotic syndrome in lupus nephropathy]. (1981) (0)
- [The dialogue between the Italian Society of Nephrology (SIN) and the health system institutions: performance evaluation of nephrology care]. (2012) (0)
- Clinical significance of an impaired mononuclear phagocyte system immune clearance in human nephritis. (1989) (0)
- FC048: New Tool to Predict the Clinical Course and Renal Failure in Patients with Immunoglobulin a Nephropathy (2022) (0)
- Molecular diagnosis of Alport syndrome: the experience in Siena. (1997) (0)
- 2) INTERFERON REGULATED IMMUNOPROTEASOMES IN CLINICAL AND PATHOLOGY FEATURES OF PATIENTS WITH IGAN. GENETIC AND PHENOTYPIC STUDY (2012) (0)
- Association between genes conditioning low renin angiotensin system activity (ras) and severe hypodysplastic congenital nephropathy. (2003) (0)
- [Treatment of fluid overload and kidney failure with periotoneal dialysis after heart surgery]. (2000) (0)
- [Acute renal failure and acute abdomen]. (1976) (0)
- [Use of corticotherapy in the treatment of idiopathic glomerulonephritis]. (1981) (0)
- [Assessing early diagnosis of kidney disease is important for the patient and for the nephrologist's professional image]. (2011) (0)
- [SIN ECM activity 2007-2008 and program 2009]. (2009) (0)
- [Use of information computers in the clinical management of the periodic hemodialysis treatment]. (1973) (0)
- Immunotactoid Glomerulopathy: What about Therapy? (1989) (0)
- [Use of the dinitrochlorobenzene test in evaluation of cellular immunity in uremic patients]. (1979) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rosanna Coppo?
Rosanna Coppo is affiliated with the following schools:
